| Mrs Leila Patricia Julien, LPN | |
|
870 E 29th St, Brooklyn, NY 11210-2927 | |
| (718) 421-2574 | |
| (347) 394-5181 |
| Full Name | Mrs Leila Patricia Julien |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 870 E 29th St, Brooklyn, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003448069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 292600 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Leila Patricia Julien, LPN 870 E 29th St, Brooklyn, NY 11210-2927 Ph: (718) 421-2574 | Mrs Leila Patricia Julien, LPN 870 E 29th St, Brooklyn, NY 11210-2927 Ph: (718) 421-2574 |
News Archive
Chemists at the California Institute of Technology (Caltech) and The Scripps Research Institute (SRI) have developed an innovative technique to create cheap but highly stable chemicals that have the potential to take the place of the antibodies used in many standard medical diagnostic tests. James R. Heath, Ph.D., principal investigator of the Nanosystems Biology Cancer Center at Caltech, one of eight Centers of Cancer Nanotechnology Excellence, and K. Barry Sharpless, Ph.D., SRI, and their colleagues describe the new technique in the journal Angewandte Chemie International Edition.
It is believed the source of the latest E. coli outbreak in the United States in which 11 Taco Bells restaurants have been implicated, could be a distribution center in New Jersey.
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, announces a successful meeting with the US Food and Drug Administration (FDA) to discuss the Company's clinical development of its Aganocide compound NVC-422, intended for use in the treatment of impetigo.
› Verified 1 days ago
Jillian Byron, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1488a E 52nd St, Brooklyn, NY 11234 Phone: 347-512-4044 | |
Jonneka Ferguson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 174 E 51st St, Brooklyn, NY 11203 Phone: 718-671-2100 | |
Marlon Artito Hinds, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 120 E 57th St, Brooklyn, NY 11203 Phone: 347-957-7352 | |
Ludenie Arecy, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2505 Tilden Ave, Brooklyn, NY 11226 Phone: 718-941-4490 Fax: 718-703-1716 | |
Yvette Jubuisson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2920 Cortelyou Rd, Brooklyn, NY 11226 Phone: 718-287-4300 Fax: 718-287-4600 | |
Rodgeria Augustine, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 287 Linden Blvd, Apt D2, Brooklyn, NY 11226 Phone: 646-355-5052 | |
Elizabeth Obiamaka Obiora I, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 140 E New York Ave, 4-f, Brooklyn, NY 11225 Phone: 347-455-7507 |